SetPoint Medical today announced the first patients in Chicago have been treated with the SetPoint System, an FDA-approved neuroimmune modulation therapy for adults living with moderately-to-severely ...

Setpoint’s acquisition of inTENT Fulfillment will add experienced leaders and broaden ratings agency approvals for its asset-backed finance platform. AI Summary Setpoint, an operating system for asset ...

Setpoint, the operating system for asset-backed finance, today announced that it has signed an agreement to acquire inTENT Fulfillment, a specialized loan diligence and transaction management firm ...

SetPoint System® is first-of-its-kind neuroimmune modulation device for the treatment of adults living with moderate-to-severe rheumatoid arthritis SetPoint Medical, a commercial-stage medical ...

American corporations SetPoint Medical announced on 31st (local time) that its electroceutical for treating rheumatoid arthritis has received Food and Drug Administration (FDA) approval.

Responsive and satisfying buttons. Smooth and silent scrolling. Intuitive and useful gesture controls. Well-implemented haptic feedback. Precise sensor. Great customization software. Impressive ...

Fresh after getting the green light from the U.S. Food and Drug Administration, SetPoint Medical raises $140 million to market and distribute its rheumatoid arthritis treatment. SetPoint Medical Chief ...

SetPoint Medical, a Valencia-based company dedicated to developing therapies for people living with chronic autoimmune diseases, raised $140 million in private financing that includes $25 million in ...

SetPoint Medical has secured $140m through private financing, earmarked for the commercial rollout of the SetPoint System, a neuroimmune modulation therapy designed for patients with ...

Shortly after obtaining a green light from the FDA, SetPoint Medical announced $140 million in new funding to juice the commercialization of its neuromodulation implant for rheumatoid arthritis. The ...

This story was originally published on MedTech Dive. To receive daily news and insights, subscribe to our free daily MedTech Dive newsletter. SetPoint Medical said Monday that it raised $140 million ...

The U.S. Food and Drug Administration has approved the SetPoint System, a neuroimmune modulation device for the treatment of adults living with moderate-to-severe rheumatoid arthritis (RA). The ...